Source: Annual Congress 2006 - New methods to diagnose tuberculosis infection
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
V. Bosshard, P. Roux-Lombard, T. Perneger, M. Metzger, R. Vivien, T. Rochat, J. P. Janssens (Geneva, Switzerland). Contribution of the T-SPOT.TB assay for differentiating active versus latent tuberculosis infection (LTBI). Eur Respir J 2006; 28: Suppl. 50, 2176

Member's Comments

No comment yet.

Related content which might interest you: Comparison of a T-cell-based assay with tuberculin skin testing (TST) for diagnosis of latent tuberculosis infection (LTBI) in contact-tracing procedures Source: Annual Congress 2005 - Diagnosis of tuberculosis and LTBI Year: 2005 QFT-GIT vs TST in diagnosis of latent tuberculosis infection (LTBI) in Poland Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011 Contribution of the T-SPOT.TB assay for detection of latent tuberculous infection (LTBI) in contact tracing procedures Source: Annual Congress 2006 - New methods to diagnose tuberculosis infection Year: 2006 Interferon-γ release assays (IGRA) vs. tuberculin skin testing (TST) for detecting latent tuberculosis infection (LTBI) in chronic hemodialysis (CH) patients Source: Annual Congress 2008 - New tools in tuberculosis diagnosis Year: 2008 The effect of smoking on QuantiFERON results in diagnosis of latent tuberculosis infection Source: International Congress 2016 – Latent tuberculosis infection Year: 2016 QuantiFERON-TB GIT (QFT-GIT) vs TST in diagnosis of latent tuberculosis (TB) infection (LTBI) in household TB contacts in poland Source: Annual Congress 2009 - Tuberculosis contact screening Year: 2009 What is latent tuberculosis infection (LTBI)? Source: Annual Congress 2009 - Microbial colonisation or latency: a foot in the door to respiratory infections Year: 2009 The role of quantiferon tuberculosis gold test (Q) in diagnosing active tuberculosis (TB) and latent tuberculosis infection (LTI) in children Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment Year: 2008 Cost-effectiveness of interferon-γ release assay testing for the treatment of latent tuberculosis Source: Eur Respir J 2007; 30: 321-332 Year: 2007 Comparison of tuberculin skin test (TST) and QuantiFERON-TB-Gold in Tube (QFT) in the diagnosis of latent tuberculosis infection (LTBI) in a prospective community study of contacts of tuberculosis (TB) Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis? Year: 2010 Interferon-gamma release assays (IGRA) for latent tuberculosis infection (LTBI) in children Source: Annual Congress 2011 - Tuberculosis in pregnancy and childhood Year: 2011 A combinatorial dual-immunoassay predicts reactivation risk for patients with previously incomplete treatment for latent tuberculosis infection Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016 The value of tuberculin skin test (TST) and interferon – gamma release assay (IGRA) in the diagnosis of latent tuberculosis infection (LTBI) according to age group Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis Year: 2010 LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement Source: Eur Respir J 2009; 33: 956-973 Year: 2009 Direct costs of three models for the screening of latent tuberculosis infection Source: Eur Respir J 2006; 28: 45-50 Year: 2006 New immunologic tools for the diagnosis and therapy of tuberculosis Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem Year: 2005 The treatment of tuberculosis and application of HAART (highly active anti retroviral treatment) in HIV positive patients Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem Year: 2005 Quantiferon-TB Gold in tube assay for detecting latent TB infection in immigrants and TB contacts Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013 A comparison of on-site versus remote physician follow up of directly observed preventive treatment (DOPT) for latent tuberculosis infection (LTBI) on completion rates Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II Year: 2012 Interferon-γ release assays (IGRA) for detecting latent tuberculosis (LTBI) after lung transplantation (LTX) Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous Year: 2008